Cardiology

Lixisenatide doesn't affect cardiovascular risk in T2DM

(HealthDay)—The addition of lixisenatide to usual care does not impact the rate of major cardiovascular events or other serious adverse events among patients with type 2 diabetes and a recent acute coronary syndrome, according ...

Cardiology

Study quells concerns about NSAID safety

In older patients with arthritis and no history of cardiovascular disease, chronic use of any non-steroidal anti-inflammatory drug appears safe from a cardiovascular and gastrointestinal stand-point, and regular, non-selective ...

Diabetes

Risk of death up with lower extremity amputation in diabetes

(HealthDay)—Patients with diabetes and a lower extremity amputation (LEA) are more likely to die, with some of the increased risk due to diabetes-related complications, according to a study published online July 22 in Diabetes ...

page 32 from 40